Review of Outcomes after Diagnosis of Malignancy in Kidney Transplant Patients: UNOS Database

Malignancy is the third major cause of death among transplant recipients. Patient and kidney outcomes after diagnosis malignancy are not well described. We reviewed incidences colorectal, lung, PTLD, renal patients who received a from January 2000 to December 2018 using UNOS/OPTN database. Incidence each was measured at 5 years 10 transplant. The Kaplan–Meier curve used for time-to-event analysis (graft patient outcomes). Additionally, we sought identify causes graft failure these found that 12,764 (5.5%) suffered malignancy, excluding squamous basal cell skin carcinoma During first transplant, incidence malignancies 2.99, 9.21, 15.61, 8.55 per 10,000 person-years, respectively. Rates were 10.3%, 7.6%, 19.9%, 18.8%, respectively, years. Mortality rate highest lung (84%), followed by colorectal (61.5%), PTLD (49.1%), (35.5%) malignancy. In conclusion, recipients diagnosed with have lowest survival, compared has in